Literature DB >> 19756829

Circulating endocannabinoid concentrations during orthostatic stress.

Christoph Schroeder1, Sandor Batkai, Stefan Engeli, Jens Tank, André Diedrich, Friedrich C Luft, Jens Jordan.   

Abstract

BACKGROUND: In animals, the endocannabinoid system is activated during hemodynamic insults and restrains blood pressure in part through sympathetic inhibition.
MATERIALS AND METHODS: We tested the hypothesis that hemodynamic stress elicited by head-up tilt testing increases systemic endocannabinoid concentrations in humans and that excessive endocannabinoid availability predisposes to presyncope.
RESULTS: With head-up tilt, 2-arachidonoylglycerol increased, whereas anandamide remained unchanged.
CONCLUSIONS: In contrast to our expectations, anandamide plasma concentration at rest was directly correlated with orthostatic tolerance, rather than intolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756829     DOI: 10.1007/s10286-009-0026-1

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  13 in total

Review 1.  The molecular logic of endocannabinoid signalling.

Authors:  Daniele Piomelli
Journal:  Nat Rev Neurosci       Date:  2003-11       Impact factor: 34.870

2.  Uptake blockade of endocannabinoids in the NTS modulates baroreflex-evoked sympathoinhibition.

Authors:  Daniel T Brozoski; Caron Dean; Francis A Hopp; Jeanne L Seagard
Journal:  Brain Res       Date:  2005-09-09       Impact factor: 3.252

3.  Daytime variability in carotid baroreflex function in healthy human subjects.

Authors:  Victoria L Cooper; Mark W Elliott; Stan B Pearson; Claire M Taylor; Roger Hainsworth
Journal:  Clin Auton Res       Date:  2007-01-30       Impact factor: 4.435

4.  Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity.

Authors:  Matthias Blüher; Stefan Engeli; Nora Klöting; Janin Berndt; Mathias Fasshauer; Sándor Bátkai; Pál Pacher; Michael R Schön; Jens Jordan; Michael Stumvoll
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461

5.  Endogenous cannabinoids mediate hypotension after experimental myocardial infarction.

Authors:  J A Wagner; K Hu; J Bauersachs; J Karcher; M Wiesler; S K Goparaju; G Kunos; G Ertl
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

6.  Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system.

Authors:  Torsten Pfitzer; Nathalie Niederhoffer; Bela Szabo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-01-20       Impact factor: 3.000

7.  Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.

Authors:  N Niederhoffer; B Szabo
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

8.  Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.

Authors:  J A Wagner; K Varga; E F Ellis; B A Rzigalinski; B R Martin; G Kunos
Journal:  Nature       Date:  1997-12-04       Impact factor: 49.962

9.  Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.

Authors:  Sándor Bátkai; Pál Pacher; Douglas Osei-Hyiaman; Svetlana Radaeva; Jie Liu; Judith Harvey-White; László Offertáler; Ken Mackie; M Audrey Rudd; Richard D Bukoski; George Kunos
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

Review 10.  The origin of vasovagal syncope: to protect the heart or to escape predation?

Authors:  Paolo Alboni; Marco Alboni; Giorgio Bertorelle
Journal:  Clin Auton Res       Date:  2008-06-30       Impact factor: 5.625

View more
  9 in total

Review 1.  Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?

Authors:  Cecilia J Hillard
Journal:  Neuropsychopharmacology       Date:  2017-06-27       Impact factor: 7.853

2.  Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats.

Authors:  Natale R Sciolino; Wenyi Zhou; Andrea G Hohmann
Journal:  Pharmacol Res       Date:  2011-05-11       Impact factor: 7.658

Review 3.  Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.

Authors:  C J Hillard; K M Weinlander; K L Stuhr
Journal:  Neuroscience       Date:  2011-11-17       Impact factor: 3.590

4.  Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans.

Authors:  Andrea Dlugos; Emma Childs; Kara L Stuhr; Cecilia J Hillard; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2012-07-04       Impact factor: 7.853

5.  Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS.

Authors:  Flaminia Fanelli; Valentina D Di Lallo; Ilaria Belluomo; Rosaria De Iasio; Margherita Baccini; Elena Casadio; Daniela Ibarra Gasparini; Michelangelo Colavita; Alessandra Gambineri; Gabriele Grossi; Valentina Vicennati; Renato Pasquali; Uberto Pagotto
Journal:  J Lipid Res       Date:  2011-12-14       Impact factor: 5.922

6.  Endocannabinoids as potential biomarkers: It's all about pre-analytics.

Authors:  Daniel Kratz; Dominique Thomas; Robert Gurke
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2021-11-10

Review 7.  Endocannabinoid signaling in the etiology and treatment of major depressive illness.

Authors:  Cecilia J Hillard; Qing-song Liu
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

8.  Aerobic exercise reduces anxiety and fear ratings to threat and increases circulating endocannabinoids in women with and without PTSD.

Authors:  Kevin M Crombie; Josh M Cisler; Cecilia J Hillard; Kelli F Koltyn
Journal:  Ment Health Phys Act       Date:  2020-11-02

9.  Loneliness, Circulating Endocannabinoid Concentrations, and Grief Trajectories in Bereaved Older Adults: A Longitudinal Study.

Authors:  Minhi Kang; Luisa Bohorquez-Montoya; Timothy McAuliffe; Stacy A Claesges; Nutta-On Blair; Garrett Sauber; Charles F Reynolds; Cecilia J Hillard; Joseph S Goveas
Journal:  Front Psychiatry       Date:  2021-12-08       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.